Cargando…
Metabotropic glutamate receptor 5: a target for migraine therapy
INTRODUCTION: Many patients suffering from migraine gain little relief from existing treatments partly because many existing acute and preventive therapies used in migraine have been adopted from other neurologic conditions such as depression or epilepsy. Here, we present data supporting a new migra...
Autores principales: | Waung, Maggie W., Akerman, Simon, Wakefield, Mark, Keywood, Charlotte, Goadsby, Peter J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999590/ https://www.ncbi.nlm.nih.gov/pubmed/27606340 http://dx.doi.org/10.1002/acn3.302 |
Ejemplares similares
-
A proof-of-concept study evaluating the effect of ADX10059, a metabotropic glutamate receptor-5 negative allosteric modulator, on acid exposure and symptoms in gastro-oesophageal reflux disease
por: Keywood, C, et al.
Publicado: (2009) -
Metabotropic glutamate receptor 5 in bulimia nervosa
por: Mihov, Yoan, et al.
Publicado: (2020) -
Metabotropic Glutamate Receptors for Parkinson's Disease Therapy
por: Gasparini, Fabrizio, et al.
Publicado: (2013) -
Metabotropic glutamate receptors inhibit microglial glutamate release
por: McMullan, Stephen M, et al.
Publicado: (2012) -
Targeting metabotropic glutamate receptors for novel treatments of schizophrenia
por: Maksymetz, James, et al.
Publicado: (2017)